COVID-19 Coronavirus Business Impact: Securities Litigation, SEC Guidance and Strategies to Minimize Risk

As COVID-19 continues to impact corporations’ operations and financial results, as well as markets in general, we anticipate an increase in securities related litigation following any significant stock declines, as well as an increase in derivative actions arising from alleged failure of corporate oversight. Join us for a discussion regarding the anticipated wave of securities litigation arising from COVID-19, related SEC guidance and strategies public companies can use to minimize the risk of securities class actions or shareholder derivative actions. Issues we will discuss include:

• Anticipated securities litigation.
• Recent SEC guidance regarding corporate disclosures.
• Drafting disclosures in light of the myriad issues facing companies as a result of COVID-19.Dividends, disavowing guidance and other related issues.
• Strategies to minimize the risk of derivative actions, including issues relating to corporate oversight and corporate governance matters.